IMS commercial effectiveness services team unveils comprehensive review, to date, of physicians and…
The IMS Health Physician and Chemist Census provides unprecedented insights into this stakeholder group, and uncovers significant…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
DIA names Barbara Lopez Kunz as Global Chief Executive
Worldwide life sciences business leader to bring new vision and momentum to DIA
Novartis accredited with global ‘CEO Cancer Gold Standard’ for outstanding efforts in…
Non-profit organisation CEO Roundtable on Cancer has recognised the programmes Novartis has to support associates in the…
Ranbaxy allocated site for its greenfield manufacturing facility in Malaysia
Agreement signed with Kulim Hi Tech Park
Ion Exchange (India) unveils new corporate identity
The new logo celebrates the greenery and water around and more cogently reaffirms the constant effort to make the earth a better…
Jubilant Biosys files IND with US-based Endo Pharmaceuticals
IND relates to a novel molecule targeting prostate cancer which will now progress towards the next stage of development, with…
Lupin signs agreement with Romark Laboratories
Announces acquisition of exclusive US Rights to Alinia for oral suspension
Sorrento Therapeutics and Lonza sign research license agreement for GS Xceed Gene Expression System
The GS Xceed System will be used in the generation of stable expression cell lines for the production and development of…
USP appoints Michael D Maves as Senior Vice President of Development
Previously served on USP’s Board of Trustees
Piramal Enterprises receives IND approval from US FDA
P7435 is a novel DGAT1 inhibitor for treatment of lipid disorders and diabetes